As pharma anticipates the forthcoming Brexit negotiations and future uncertainty, Stephie Castling, senior marketing executive from Denny Bros, examines the regulatory concerns coming to the fore in the industry.
With bated breath
As the country holds its breath over Brexit negotiations and an uncertain future, the pharmaceutical industry is understandably starting to ask questions. One of the current concerns is around the future of the EU’s Falsified Medicines Directive (FMD).